Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism

Jin Wook Kim, Du Geon Moon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Testosterone is the principal androgen in the human male. The decline of testosterone with aging was recognized to be associated with a number of symptoms and signs that reduce the quality of life and that may even have severe, debilitating consequences. Clinically, late-onset hypogonadism (LOH) is diagnosed by use of biochemical and clinical measures. Despite published guidelines and recommendations, however, uncertainty surrounds the profile of clinical symptoms as well as the biochemical threshold of diagnosis. Clinicians should be aware of these shortcomings while adhering to the guidelines. Current treatment methods are centered on restoring testosterone to mid to lower levels of young men with natural testosterone replacements. Although recent studies have highlighted possible additional benefits involving improvement of systemic disorders, the goal of treatment is to improve sexual function, while observing for adverse effects in the prostate. Overall, the problem of LOH in debilitating the quality of life and well-being is real, and by following proper guidelines with attentiveness to the results of treatment trials, testosterone replacement therapy presents a safe and effective treatment option.

Original languageEnglish
Pages (from-to)725-735
Number of pages11
JournalKorean Journal of Urology
Volume52
Issue number11
DOIs
Publication statusPublished - 2011 Nov 1

Fingerprint

Hypogonadism
Testosterone
Guidelines
Quality of Life
Therapeutics
Androgens
Signs and Symptoms
Uncertainty
Prostate

Keywords

  • Erectile dysfunction
  • Hormone replacement therapy
  • Hypogonadism
  • Libido
  • Testosterone

ASJC Scopus subject areas

  • Urology

Cite this

Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism. / Kim, Jin Wook; Moon, Du Geon.

In: Korean Journal of Urology, Vol. 52, No. 11, 01.11.2011, p. 725-735.

Research output: Contribution to journalArticle

@article{5932f02a8b9f4820aa476e430264848a,
title = "Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism",
abstract = "Testosterone is the principal androgen in the human male. The decline of testosterone with aging was recognized to be associated with a number of symptoms and signs that reduce the quality of life and that may even have severe, debilitating consequences. Clinically, late-onset hypogonadism (LOH) is diagnosed by use of biochemical and clinical measures. Despite published guidelines and recommendations, however, uncertainty surrounds the profile of clinical symptoms as well as the biochemical threshold of diagnosis. Clinicians should be aware of these shortcomings while adhering to the guidelines. Current treatment methods are centered on restoring testosterone to mid to lower levels of young men with natural testosterone replacements. Although recent studies have highlighted possible additional benefits involving improvement of systemic disorders, the goal of treatment is to improve sexual function, while observing for adverse effects in the prostate. Overall, the problem of LOH in debilitating the quality of life and well-being is real, and by following proper guidelines with attentiveness to the results of treatment trials, testosterone replacement therapy presents a safe and effective treatment option.",
keywords = "Erectile dysfunction, Hormone replacement therapy, Hypogonadism, Libido, Testosterone",
author = "Kim, {Jin Wook} and Moon, {Du Geon}",
year = "2011",
month = "11",
day = "1",
doi = "10.4111/kju.2011.52.11.725",
language = "English",
volume = "52",
pages = "725--735",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "11",

}

TY - JOUR

T1 - Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism

AU - Kim, Jin Wook

AU - Moon, Du Geon

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Testosterone is the principal androgen in the human male. The decline of testosterone with aging was recognized to be associated with a number of symptoms and signs that reduce the quality of life and that may even have severe, debilitating consequences. Clinically, late-onset hypogonadism (LOH) is diagnosed by use of biochemical and clinical measures. Despite published guidelines and recommendations, however, uncertainty surrounds the profile of clinical symptoms as well as the biochemical threshold of diagnosis. Clinicians should be aware of these shortcomings while adhering to the guidelines. Current treatment methods are centered on restoring testosterone to mid to lower levels of young men with natural testosterone replacements. Although recent studies have highlighted possible additional benefits involving improvement of systemic disorders, the goal of treatment is to improve sexual function, while observing for adverse effects in the prostate. Overall, the problem of LOH in debilitating the quality of life and well-being is real, and by following proper guidelines with attentiveness to the results of treatment trials, testosterone replacement therapy presents a safe and effective treatment option.

AB - Testosterone is the principal androgen in the human male. The decline of testosterone with aging was recognized to be associated with a number of symptoms and signs that reduce the quality of life and that may even have severe, debilitating consequences. Clinically, late-onset hypogonadism (LOH) is diagnosed by use of biochemical and clinical measures. Despite published guidelines and recommendations, however, uncertainty surrounds the profile of clinical symptoms as well as the biochemical threshold of diagnosis. Clinicians should be aware of these shortcomings while adhering to the guidelines. Current treatment methods are centered on restoring testosterone to mid to lower levels of young men with natural testosterone replacements. Although recent studies have highlighted possible additional benefits involving improvement of systemic disorders, the goal of treatment is to improve sexual function, while observing for adverse effects in the prostate. Overall, the problem of LOH in debilitating the quality of life and well-being is real, and by following proper guidelines with attentiveness to the results of treatment trials, testosterone replacement therapy presents a safe and effective treatment option.

KW - Erectile dysfunction

KW - Hormone replacement therapy

KW - Hypogonadism

KW - Libido

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84255198445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255198445&partnerID=8YFLogxK

U2 - 10.4111/kju.2011.52.11.725

DO - 10.4111/kju.2011.52.11.725

M3 - Article

VL - 52

SP - 725

EP - 735

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 11

ER -